Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Research and Development Expenses, Net (Tables)

v3.19.1
Research and Development Expenses, Net (Tables)
 12 Months Ended
Dec. 31, 2018
Research and Development Expenses, Net [Abstract]  
Schedule of research and development expenses
    Year ended December 31  
    2018     2017     2016  
                   
Salaries and related expenses   $ 178,486     $ 144,250     $ 145,997  
Stock-based compensation     12,077       22,883       48,056  
Professional fees     22,271       18,888       37,426  
Laboratory and materials     70,779       143,644       109,299  
Patent expenses     82,367       65,654       24,956  
Rent and maintenance     40,146       41,673       41,289  
Liability for minimum royalty expenses (*)     --       238,000       50,000  
Depreciation     25,650       24,083       20,695  
Travel expenses     3,804       2,152       2,942  
Insurance and other expenses     23,604       19,300       3,293  
      459,184       720,527       483,953  
Less: Grants from the OCS and others (**)     -       -       (166,046 )
    $ 459,184     $ 720,527     $ 317,907  

 

(*) See Note 10B.

 

(**) See Note 10A and 10D.